Five-Year Study Demonstrates PASV® Valve Technology in Boston Scientific's PICC Catheters Significantly Reduced Rates of Both Occlusion and Infection
(January 18, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced the results of a five-year retrospective study on Peripherally Inserted Central Catheters (PICCs) with Pressure Activated Safety Valve (PASV®) Technology, indicating a significant reduction in rates of both occlusion (closure) and infection. The study, conducted by Vanderbilt University Medical Center (VUMC) in Nashville, TN was presented at the Association for Vascular Access (AVA) Annual Conference in Savannah, GA.

PICCs provide reliable access to the blood stream for patients requiring intravenous antibiotics, total parenteral nutrition, chemotherapy, blood products and blood sampling. The Vanderbilt study collected data over a five-year period on more than 12,500 PICC procedures performed by trained personnel in VUMC